Prescient Therapeutics (ASX: PTX) has received fast-track designation from the US Food and Drug Administration for lead ...

Pembrolizumab demonstrated clinical activity in patients with mycosis fungoides (MF ... The median progression-free survival was 7.4 months, and the median overall survival was 20.6 months.

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

Interim Results from FDA-Funded Study Reinforces HyBryte's Rapid Response and Strong Safety Profile PRINCETON, N.J., April 14, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix ...

Most skin lymphomas have an excellent prognosis. However, there are more aggressive ... 24876 National Library of Medicine. Mycosis fungoides. National Library of Medicine. Sézary syndrome. Lymphoma ...

High-potency Class I to II topicals are frequently used first line to suppress inflammation and symptoms of itching. These agents are often useful as therapy for stage IA disease, but are often ...

You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your ...

"THE OPERATION IS OVER! THE PATIENT LIVED, AND IS HEALING," Trump wrote on Truth Social. "THE PROGNOSIS IS THAT THE PATIENT WILL BE FAR STRONGER, BIGGER, BETTER, AND MORE RESILIENT THAN EVER BEFORE.

Mellencamp revealed in another interview with Nightline that doctors have given her a 50/50 chance of survival. "My tumors have significantly shrunk, which doctors believe means that this all will ...

The prescribed dosage for dexamethasone may vary depending on a person’s individual treatment plan. Factors such as your medical history and body weight may also affect your dosage of ...

Gut Microbiota in Immuno-Oncology: A Practical Guide for Medical Oncologists With a Focus on Antibiotics Stewardship Bispecific antibodies (bsAbs) have emerged as a novel class of therapeutics, ...